Gerresheimer AG shares advanced 5.7% to €26.68 on Monday, extending a recent rebound after preliminary first-quarter 2026 results highlighted stronger cash generation despite a decline in profitability metrics.
The Düsseldorf-based pharmaceutical packaging specialist has traded mostly in the upper €20 range throughout August, recovering from a 52-week low of €26.68 but still well below its peak of €45.24 reached last year. The stock’s recent uptick follows the release of preliminary quarterly figures that underscore a strategic pivot toward liquidity over near-term earnings.
Revenue for the period reached €524 million, a modest increase from €519 million in the same quarter a year earlier on an adjusted basis. Adjusted EBITDA, however, declined to €66 million from €81 million, while the EBITDA margin narrowed to 12.6% from 15.7%, reflecting deliberate cost prioritization aimed at bolstering free cash flow. The company, which remains listed on the SDAX, had previously guided 2026 revenue toward the lower end of its €2.3–€2.4 billion range.
Leadership changes at the helm accompanied the financial update. Uwe Röhrhoff, the outgoing CEO, stepped down effective immediately, with interim joint leadership assigned to Wolf Lehmann and Achim Schalk. The transition was formalized on August 24, 2026, just days before the preliminary results were published.
The company’s focus on cash generation over margin expansion has been a central theme in its recent strategy, as investors weigh the trade-off between short-term earnings pressure and long-term financial resilience.
